Tissue plasminogen activator is a potent activator of PDGF-CC

AUTOR(ES)

Fredriksson, Linda

FONTE

Nature Publishing Group

RESUMO

Tissue plasminogen activator (tPA) is a serine protease involved in the degradation of blood clots through the activation of plasminogen to plasmin. Here we report on the identification of tPA as a specific protease able to activate platelet-derived growth factor C (PDGF-C). The newly identified PDGF-C is secreted as a latent dimeric factor (PDGF-CC) that upon proteolytic removal of the N-terminal CUB domains becomes a PDGF receptor α agonist. The CUB domains in PDGF-CC directly interact with tPA, and fibroblasts from tPA-deficient mice fail to activate latent PDGF-CC. We further demonstrate that growth of primary fibroblasts in culture is dependent on a tPA-mediated cleavage of latent PDGF-CC, generating a growth stimulatory loop. Immunohistochemical analysis showed similar expression patterns of PDGF-C and tPA in developing mouse embryos and in tumors, indicating both autocrine and paracrine modes of activation of PDGF receptor-mediated signaling pathways. The identification of tPA as an activator of PDGF signaling establishes a novel role for the protease in normal and pathological tissue growth and maintenance, distinct from its well-known role in plasminogen activation and fibrinolysis.

Documentos Relacionados

• Revascularization of ischemic tissues by PDGF-CC via effects on endothelial cells and their progenitors
• A faster-acting and more potent form of tissue plasminogen activator.
• Regulation of seizure spreading by neuroserpin and tissue-type plasminogen activator is plasminogen-independent
• Tissue-type plasminogen activator is a target of the tumor suppressor gene maspin
• Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.